A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology.

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

In vitro studies pinpoint signaling pathways that could be potential targets in oral squamous cell carcinoma treatments.

Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

This review synthesizes preclinical evidence showing that cinnamon-derived compounds can modulate inflammation, oxidative ...

A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...

Cancer is often perceived as a fate, but what if it could be avoided even before it manifests? Scientists have just taken a significant step in that direction. Their work on mice reveals that ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...